These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11154823)

  • 1. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase.
    Grierson AJ; Johnson GV; Miller CC
    Neurosci Lett; 2001 Jan; 298(1):9-12. PubMed ID: 11154823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination.
    Tucholski J; Kuret J; Johnson GV
    J Neurochem; 1999 Nov; 73(5):1871-80. PubMed ID: 10537045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase cross-linking of the tau protein.
    Miller ML; Johnson GV
    J Neurochem; 1995 Oct; 65(4):1760-70. PubMed ID: 7561874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
    Dudek SM; Johnson GV
    J Neurochem; 1993 Sep; 61(3):1159-62. PubMed ID: 8103081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
    Norlund MA; Lee JM; Zainelli GM; Muma NA
    Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
    Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA
    J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
    Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
    Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
    Appelt DM; Balin BJ
    Brain Res; 1997 Jan; 745(1-2):21-31. PubMed ID: 9037390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe.
    Lee KN; Maxwell MD; Patterson MK; Birckbichler PJ; Conway E
    Biochim Biophys Acta; 1992 Jul; 1136(1):12-6. PubMed ID: 1353685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase is an in situ substrate of calpain: regulation of activity.
    Zhang J; Guttmann RP; Johnson GV
    J Neurochem; 1998 Jul; 71(1):240-7. PubMed ID: 9648871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the amine acceptor protein substrates of transglutaminase with 5-(biotinamido) pentylamine.
    Singh RN; McQueen T; Mehta K
    Anal Biochem; 1995 Oct; 231(1):261-3. PubMed ID: 8678310
    [No Abstract]   [Full Text] [Related]  

  • 13. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
    Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
    J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase activity is increased in Alzheimer's disease brain.
    Johnson GV; Cox TM; Lockhart JP; Zinnerman MD; Miller ML; Powers RE
    Brain Res; 1997 Mar; 751(2):323-9. PubMed ID: 9099822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.
    Pijnenburg YA; Janssen JC; Schoonenboom NS; Petzold A; Mulder C; Stigbrand T; Norgren N; Heijst H; Hack CE; Scheltens P; Teunissen CE
    Dement Geriatr Cogn Disord; 2007; 23(4):225-30. PubMed ID: 17290105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.
    Selkoe DJ; Abraham C; Ihara Y
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6070-4. PubMed ID: 6136967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity.
    Johnson GV; LeShoure R
    J Neurosci Methods; 2004 Apr; 134(2):151-8. PubMed ID: 15003381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking.
    Perry MJ; Mahoney SA; Haynes LW
    Neuroscience; 1995 Apr; 65(4):1063-76. PubMed ID: 7617162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive hyperphosphorylation of neurofilament heavy subunits with aging: possible involvement in the mechanism of neurofilament accumulation.
    Gou JP; Eyer J; Leterrier JF
    Biochem Biophys Res Commun; 1995 Oct; 215(1):368-76. PubMed ID: 7575615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.